CBD study: 12 weeks of study medication (cannabidiol (Epidyolex) or placebo) for ages 6-17 to evaluate change in symptoms in Autism Spectrum Disorder
- Assessment for the diagnosis of autism and to assess the severity of autism
- 3 clinic visits to UCSF and 7 telephone visits
- There will be blood draws and ECG
- Exclusion criteria
ADHD or other diagnoses that dominates the clinical presentation Axial study (Gut Metabolite Supplementation): 8 weeks trial of study medication or placebo for ages 13-17 with GI symptoms to evaluate the effects of this supplement, which coats irritating metabolites in the gut to attempt to reduce irritability in Autism.
- 6 clinic visits to UCSF and 3 phone visits
- Exclusion criteria : history of inflammatory bowel disease, history of diabetes, certain medications.
- There will be blood draws and ECG
ANCHOR (Irritability Associated with ASD; Otsuka) Study: Brexpiprazole is a recently developed medication to reduce irritability associated with Autism: Treatment with study medication (medication or placebo) for 8 weeks for ages 5-17 followed by extension study (on medication) for 26 weeks.
- Combination of 4 clinic visits at UCSF, 4 virtual visits and one phone visit.
- There will be blood draws, ECG and testing.
Write a review
temp mail ( 11/09/2024 )
Looking forward to your next post. Keep up the good work!